Traxion Sab De Cv Ord Shs GRPOF

Apotex

[Catalystking519]

Apotex is a leader in the North American generic pharmaceutical market with #1 ranking in Canada in terms of prescriptions filled, sales volume and value.

We are a vertically integrated company. Our preference is to develop, manufacture and market our own products — from API to finished dosage form to marketing and distribution.

Apotex does however have an interest in complimenting its own product portfolio/pipeline with products from third parties where they can offer:

• Early to market opportunities
• Dosage Forms Apotex does not manufacture

Examples of our successful collaboration with third parties:

• Partnership with Orchid Chemicals & Pharmaceuticals Ltd. for cephalosporin injectables for the Canadian markets 
• First to launch a generic oral contraceptive product in Canada (Portia®); collaboration with Barr Pharmaceuticals, Inc.

Early to market opportunities

• first-to-file
• non-infringing API and/or formulations

Apotex has substantial experience in identifying, developing, registering and defending litigation in early to market opportunities.


Tetra definitely fits some of the criteria,  early to market opportunity and first to file.  Apotex is a very possible option.